21.5 C
Delhi
Tuesday, October 7, 2025

Dr Reddy Labs launches Lenalidomide Capsules in US

Date:

Share post:

Donate-GC-Razorpay

Mumbai: Dr. Reddy’s Labs on Thursday announced the launch of Lenalidomide Capsules in the US market, , a therapeutic equivalent generic version of REVLIMID (lenalidomide) Capsules approved by U. S. Food and Drug Administration (USFDA).

With this volume-limited launch, Dr. Reddy’s is eligible for first-to-market, 180 days of generic drug exclusivity for Lenalidomide Capsules in 2.5 mg and 20 mg strengths.

‘We are pleased with the first-to-market launch of two of our six strengths of Lenalidomide Capsules with 180-day market exclusivity,” says Marc Kikuchi, CEO, North America Generics, Dr. Reddy’s Laboratories.

“Bringing a more affordable generic version to market creates greater patient access for this important drug.’

Dr. Reddy’s Lenalidomide Capsules are available in strengths of 2.5 mg, 5 mg, and 10 mg, each in a bottle-count size of 28, as well as 15 mg, 20 mg, and 25 mg strengths, each in a bottle-count size of 21.

Related articles

Goa is a Dev Bhoomi: The Land Remembers

There are lands where gods once walked - and there are lands where gods still linger. Goa is...

Zoho Will Dethrone Meta, Google and Microsoft in India

There’s a tectonic shift happening in India’s tech landscape. Not the noisy kind of shift — no extravagant...

Merit, Not Reservations, Will Build India’s Future

My views on reservations are absolutely clear and have been consistent over the years: India’s future cannot be...

Mahatma Gandhi’s 156th Birth Anniversary Observed by the Indian Embassy in Dublin

The Indian Embassy in Dublin organised a special event to pay respect and tributes to Mahatma Gandhi on...